Colorectal Carcinoma
239
48
71
106
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
42 trials with published results (18%)
Research Maturity
106 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.3%
27 terminated out of 239 trials
79.7%
-6.8% vs benchmark
7%
17 trials in Phase 3/4
40%
42 of 106 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 106 completed trials
Clinical Trials (239)
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
The Vanguard Study: Testing a New Way to Screen for Cancer
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
Confronting Cancer as a Community
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Role of Diet on the Microbiome of the Digestive System
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Testing Obeticholic Acid for Familial Adenomatous Polyposis
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis